A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities

Area of Science:

• Computational Biology
• Neuroscience
• Epidemiology

Background:

• Epilepsy patients exhibit higher incidence of nervous system diseases.
• Comorbidities like Alzheimer's and Parkinson's are seizure risk factors, suggesting shared pathophysiology.
• Initial gene overlap analysis indicated neurological disorders have the highest overlap with epilepsy.

Purpose of the Study:

• To identify shared pathophysiological mechanisms between epilepsy and its comorbidities.
• To explore genetic pleiotropy as a proxy for shared disease basis.
• To leverage knowledge assembly and comparative analysis for mechanism discovery.

Main Methods:

• Literature-based gene overlap analysis.
• Knowledge assembly using Biological Expression Language (BEL).
• Enrichment with epilepsy, risk factors, comorbidities, and anti-epileptic drug data.
• Comparative mechanism enrichment analysis.

Main Results:

• Gene overlap analysis was insufficient for identifying common mechanisms.
• A knowledge assembly approach identified potential shared effectors.
• GABA receptor and GABAergic pathways were proposed as downstream effectors.
• These pathways may explain carbamazepine's therapeutic effects in epilepsy and Alzheimer's disease.

Conclusions:

• Shared genetic and pathophysiological mechanisms exist between epilepsy and its comorbidities.
• Knowledge assembly and comparative analysis are effective for mechanism discovery.
• GABAergic pathways represent a promising target for treating both epilepsy and Alzheimer's disease.